Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $12.1000 (2.11%) ($12.1000 - $12.1000) on Tue. Nov. 8, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.95% (three month average) | RSI | 39 | Latest Price | $12.1000(2.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.3% a day on average for past five trading days. | Weekly Trend | BCRX declines -6.2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) VUG(27%) XLK(27%) URA(26%) VT(25%) BLOK(24%) | Factors Impacting BCRX price | BCRX will decline at least -1.475% in a week (0% probabilities). SMH(-18%) VIXM(-11%) EDOC(-7%) UUP(-6%) ARKG(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.475% (StdDev 2.95%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $1.29(-89.34%) | Resistance Level | $13.19 | 5 Day Moving Average | $12.09(0.08%) | 10 Day Moving Average | $12.68(-4.57%) | 20 Day Moving Average | $13.19(-8.26%) | To recent high | -18.4% | To recent low | 2.1% | Market Cap | $2.135b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |